Phase I results will be presented at the International Conference on Mucosal Vaccines, Adjuvants & Delivery, in Copenhagen
In September results of the clinical Phase I study of our novel vaccine against diarrhea caused by ETEC will be presented at the International Conference on Mucosal Vaccines, Adjuvants & Delivery, in Copenhagen.
Mucosal Vaccines, Adjuvants and Delivery is a three day conference (25-27 September) and its key focus will be on the requirements and the importance of mucosal vaccines and adjuvants in the treatment of serious disorders. Participants of this conference will get to learn about new developments made in the field of mucosal vaccines, adjuvant currently in progress, delivery systems, lessons learned from earlier and existing mucosal vaccines and considerations of the routes of immunization.
For more information about the conference please click here.